We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.06B
1-Year Est. Return 106.87%
This Fund
S&P 500
This Quarter Est. Return
+17.57%
1 Year Est. Return
+106.87%
3 Year Est. Return
+347.49%
5 Year Est. Return
+440.43%
10 Year Est. Return
+3,482.63%
AUM
$1.15B
AUM Growth
+$108M
Cap. Flow
-$17.6M
Cap. Flow %
-1.53%
Top 10 Hldgs %
19.85%
Holding
240
New
23
Increased
68
Reduced
39
Closed
28

Sector Composition

Rank Sector Weight
1 Healthcare 17.65%
2 Financials 17.49%
3 Technology 17.18%
4 Industrials 14.45%
5 Consumer Discretionary 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AX icon
76
Axos Financial
AX
$5.91B
$5.55M 0.48%
285,136
+272,196
+2,104% +$5.11M
KFY icon
77
Korn Ferry
KFY
$4.23B
$5.39M 0.47%
187,559
+722
+0.4% +$19.6K
EVDY
78
DELISTED
Everyday Health, Inc.
EVDY
$5.22M 0.45%
354,163
+118,100
+50% +$1.57M
ENPH icon
79
Enphase Energy
ENPH
$5.14B
$5.14M 0.45%
359,940
+111,350
+45% +$1.39M
ORBC
80
DELISTED
ORBCOMM, Inc.
ORBC
$5.13M 0.45%
783,961
+78,120
+11% +$492K
ATRC icon
81
AtriCure
ATRC
$1.99B
$5.02M 0.44%
251,359
+32,879
+15% +$564K
NSTG
82
DELISTED
NanoString Technologies, Inc.
NSTG
$4.97M 0.43%
356,818
-24,599
-6% -$299K
MBUU icon
83
Malibu Boats
MBUU
$550M
$4.79M 0.42%
248,486
ABAX
84
DELISTED
Abaxis Inc
ABAX
$4.74M 0.41%
83,320
+5,000
+6% +$268K
PLAY icon
85
Dave & Buster's
PLAY
$394M
$4.7M 0.41%
+172,177
New +$3.76M
KNL
86
DELISTED
Knoll, Inc.
KNL
$4.6M 0.4%
217,142
+10,550
+5% +$201K
CBK
87
DELISTED
Christopher & Banks Corporation
CBK
$4.52M 0.39%
792,099
GTT
88
DELISTED
GTT Communications, Inc.
GTT
$4.38M 0.38%
+331,380
New +$4.25M
CLAR icon
89
Clarus
CLAR
$127M
$4.13M 0.36%
473,588
+10,045
+2% +$82.9K
RARE icon
90
Ultragenyx Pharmaceutical
RARE
$2.46B
$4.08M 0.35%
93,105
+51,259
+122% +$2.35M
PRIM icon
91
Primoris Services
PRIM
$4.72B
$4.04M 0.35%
173,649
-304,428
-64% -$7.61M
BLCM
92
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$3.85M 0.33%
+16,721
New +$3.59M
CHGG icon
93
Chegg
CHGG
$113M
$3.81M 0.33%
551,720
SBNY
94
DELISTED
Signature Bank
SBNY
$3.77M 0.33%
29,915
+286
+1% +$34.1K
TPST icon
95
Tempest Therapeutics
TPST
$14.1M
$3.73M 0.32%
29
-46
-61% -$3.37M
ADMS
96
DELISTED
Adamas Pharmaceuticals
ADMS
$3.68M 0.32%
211,874
+38,654
+22% +$586K
SN
97
DELISTED
Sanchez Energy Corporation
SN
$3.49M 0.3%
+376,031
New +$5.63M
TLYS icon
98
Tilly's
TLYS
$121M
$3.37M 0.29%
347,589
-99,370
-22% -$767K
SIVB
99
DELISTED
SVB Financial Group
SIVB
$3.29M 0.29%
28,360
+129
+0.5% +$14.1K
NDLS icon
100
Noodles & Co
NDLS
$110M
$3.25M 0.28%
+15,420
New +$2.87M

Similar funds

Emerald Mutual Fund Advisers Trust's Q4 2014 Portfolio in Review

As of Q4 2014, Emerald Mutual Fund Advisers Trust held 240 positions worth $1.15B, up 10% from $1.04B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q4 2014 filing shows 23 new, 68 increased, 39 reduced and 28 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 40,227 shares worth $6.28M. The largest sale was U.S. SILICA HOLDINGS, INC., an estimated $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • Emerald Mutual Fund Advisers Trust's largest Q4 2014 buy was Intercept Pharmaceuticals, Inc.: 40,227 shares worth $6.28M.
  • Emerald Mutual Fund Advisers Trust added most to Strategy Inc in Q4 2014, an estimated $7.23M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q4 2014 reduction was Evercore, cutting an estimated $9.16M.
  • Emerald Mutual Fund Advisers Trust fully exited U.S. SILICA HOLDINGS, INC. in Q4 2014, selling an estimated $11.9M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 20% of its $1.15B portfolio in Q4 2014.
  • Emerald Mutual Fund Advisers Trust opened 23 new positions and closed 28 in Q4 2014.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 10% quarter-over-quarter to $1.15B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2014, filed 30 Jan 2015.